All Access Articles |
- Kymera Therapeutics Announces $250M Public Offering | 2025-06-30 | BIOTECHNOLOGY
- Kymera Therapeutics Plans $250M Public Offering | 2025-06-29 | BIOTECHNOLOGY
- Kymera Therapeutics Announces $250M Public Offering | 2025-06-28 | BIOTECHNOLOGY
- Kymera Therapeutics partners with Sanofi on next-gen oral IRak4 degrader, KT-485 | 2025-06-25 | BIOTECHNOLOGY
- Kymera Therapeutics Soars 46% After Positive Phase 1 Results | 2025-06-02 | BIOTECHNOLOGY
- Kymera Therapeutics Advances Oral Immunology Programs for 2025 | 2025-01-15 | BIOTECHNOLOGY